Lipid Nanoparticle-Mediated Delivery of CRISPR/Cas9 Gene Editing for Neurological Disorders.
Lipid Nanoparticle-Mediated Delivery of CRISPR/Cas9 Gene Editing for Neurological Disorders.
批准号:
456004
负责人:
Leavitt Blair R
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-09-01 至 2022-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Brain disease is a leading cause of death and disability in the Canadian population representing an immense economic and societal burden. Most brain diseases have no cure, progressively decrease quality of life, and become more common with increasing age.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lipid Nanoparticle-Mediated Delivery of CRISPR/Cas9 Gene Editing for Neurological Disorders.
-
批准号:462295
-
项目类别:Operating Grants
-
资助金额:$55.45万
-
财政年份:2022
-
负责人:Leavitt Blair R
-
依托单位:
CHAnging Rare disorders of LysInE metabolism
-
批准号:431267
-
项目类别:Operating Grants
-
资助金额:$32.78万
-
财政年份:2020
-
负责人:Leavitt Blair R
-
依托单位:
Characterization and treatment of a novel conditional mouse model of pyridoxine-dependent epileptic encephalopathy caused by antiquitin mutations.
-
批准号:419183
-
项目类别:Operating Grants
-
资助金额:$44.58万
-
财政年份:2020
-
负责人:Leavitt Blair R
-
依托单位:
Development, characterization and treatment of a novel conditional mouse model of pyridoxine-dependent epileptic encephalopathy caused by antiquitin mutations.
-
批准号:387291
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2018
-
负责人:Leavitt Blair R
-
依托单位:
In Vivo Studies to define the Role of Progranulin Mutations in Frontotemporal Dementia
-
批准号:179543
-
项目类别:Operating Grants
-
资助金额:$49.48万
-
财政年份:2009
-
负责人:Leavitt Blair R
-
依托单位:
Determination of muscle properties that alter ALS onset and disease progression using the G93A mouse model of ALS
-
批准号:186370
-
项目类别:Operating Grants
-
资助金额:$25.6万
-
财政年份:2009
-
负责人:Leavitt Blair R
-
依托单位:
海外基金